Did we do everything we could have? Nurses’ contributions to medicines optimization: A mixed-methods study
Authors: Logan, V., Keeley, S., Akerman, K., De Baetselier, E., Dilles, T., Griffin, N., Matthews, L., Van Rompaey, B. and Jordan, S.
Journal: Nursing Open
Volume: 8
Issue: 2
Pages: 592-606
eISSN: 2054-1058
DOI: 10.1002/nop2.664
Abstract:Aim: To explore UK professionals’ interpretations of medicines optimization and expansion of nurses’ roles. Design: This mixed-methods study sought professionals’ views on nurses’ involvement, competency and engagement in monitoring patients for adverse effects of medicines, monitoring adherence, prescribing and patient education. Method: An online survey and interviews were undertaken with nurses, doctors and pharmacists in Wales and England, May 2018 to July 2019. Results: In all, 220 nurses, 17 doctors and 62 pharmacists responded to the online survey, and 24 professionals were interviewed. Nurses were divided over extending their roles, with 123/220 (55.9%) wishing to extend roles in monitoring patients for possible adverse drug reactions (ADRs), 111/220 (50.5%) in adherence monitoring, 121/220 (55.0%) in prescribing and 122/220 (55.4%) in patient education. The best-qualified nurses were the most willing to increase involvement in monitoring patients for ADRs (aOR 13.00, 1.56–108.01). Interviews revealed that both nurses and doctors assumed the other profession was undertaking this monitoring. Respondents agreed that increasing nurses’ involvement in medicines optimization would improve patient care, but expressed reservations about nurses’ competencies. Collaboration between nurses and doctors was suboptimal (rated 7/10 at best) and between nurses and pharmacists even more so (6/10 at best). Conclusion: Juxtaposition of datasets identified problems with medicines optimization: although most respondents agreed that increasing nurses’ involvement would positively impact practice, their educational preparation was a barrier. Only ~50% of nurses were willing to expand their roles to fill the hiatus in care identified and ensure that at least one profession was taking responsibility for ADR monitoring. Impact: To improve multiprofessional team working and promote patient safety, nurse leaders should ensure patients are monitored for possible ADRs by at least one profession. Initiatives expanding nurses’ roles in medicines optimization and prescribing might be best targeted towards the more educated nurses, who have multidisciplinary support.
https://eprints.bournemouth.ac.uk/34712/
Source: Scopus
Did we do everything we could have? Nurses' contributions to medicines optimization: A mixed-methods study.
Authors: Logan, V., Keeley, S., Akerman, K., De Baetselier, E., Dilles, T., Griffin, N., Matthews, L., Van Rompaey, B. and Jordan, S.
Journal: Nurs Open
Volume: 8
Issue: 2
Pages: 592-606
eISSN: 2054-1058
DOI: 10.1002/nop2.664
Abstract:AIM: To explore UK professionals' interpretations of medicines optimization and expansion of nurses' roles. DESIGN: This mixed-methods study sought professionals' views on nurses' involvement, competency and engagement in monitoring patients for adverse effects of medicines, monitoring adherence, prescribing and patient education. METHOD: An online survey and interviews were undertaken with nurses, doctors and pharmacists in Wales and England, May 2018 to July 2019. RESULTS: In all, 220 nurses, 17 doctors and 62 pharmacists responded to the online survey, and 24 professionals were interviewed. Nurses were divided over extending their roles, with 123/220 (55.9%) wishing to extend roles in monitoring patients for possible adverse drug reactions (ADRs), 111/220 (50.5%) in adherence monitoring, 121/220 (55.0%) in prescribing and 122/220 (55.4%) in patient education. The best-qualified nurses were the most willing to increase involvement in monitoring patients for ADRs (aOR 13.00, 1.56-108.01). Interviews revealed that both nurses and doctors assumed the other profession was undertaking this monitoring. Respondents agreed that increasing nurses' involvement in medicines optimization would improve patient care, but expressed reservations about nurses' competencies. Collaboration between nurses and doctors was suboptimal (rated 7/10 at best) and between nurses and pharmacists even more so (6/10 at best). CONCLUSION: Juxtaposition of datasets identified problems with medicines optimization: although most respondents agreed that increasing nurses' involvement would positively impact practice, their educational preparation was a barrier. Only ~50% of nurses were willing to expand their roles to fill the hiatus in care identified and ensure that at least one profession was taking responsibility for ADR monitoring. IMPACT: To improve multiprofessional team working and promote patient safety, nurse leaders should ensure patients are monitored for possible ADRs by at least one profession. Initiatives expanding nurses' roles in medicines optimization and prescribing might be best targeted towards the more educated nurses, who have multidisciplinary support.
https://eprints.bournemouth.ac.uk/34712/
Source: PubMed
Did we do everything we could have? Nurses' contributions to medicines optimization: A mixed-methods study
Authors: Logan, V., Keeley, S., Akerman, K., De Baetselier, E., Dilles, T., Griffin, N., Matthews, L., Van Rompaey, B. and Jordan, S.
Journal: NURSING OPEN
Volume: 8
Issue: 2
Pages: 592-606
ISSN: 2054-1058
DOI: 10.1002/nop2.664
https://eprints.bournemouth.ac.uk/34712/
Source: Web of Science (Lite)
Did we do everything we could have? Nurses’ contributions to medicines optimisation: a mixed method study
Authors: Keeley, S., Logan, V., DeBaetselier, E., Dilles, T., Griffin, N., Akerman, K., Matthews, L., Rompaey, B. and Jordan, S.
Journal: Nursing Open
Publisher: Wiley Open Access
ISSN: 2054-1058
https://eprints.bournemouth.ac.uk/34712/
Source: Manual
Did we do everything we could have? Nurses' contributions to medicines optimization: A mixed-methods study.
Authors: Logan, V., Keeley, S., Akerman, K., De Baetselier, E., Dilles, T., Griffin, N., Matthews, L., Van Rompaey, B. and Jordan, S.
Journal: Nursing open
Volume: 8
Issue: 2
Pages: 592-606
eISSN: 2054-1058
ISSN: 2054-1058
DOI: 10.1002/nop2.664
Abstract:Aim
To explore UK professionals' interpretations of medicines optimization and expansion of nurses' roles.Design
This mixed-methods study sought professionals' views on nurses' involvement, competency and engagement in monitoring patients for adverse effects of medicines, monitoring adherence, prescribing and patient education.Method
An online survey and interviews were undertaken with nurses, doctors and pharmacists in Wales and England, May 2018 to July 2019.Results
In all, 220 nurses, 17 doctors and 62 pharmacists responded to the online survey, and 24 professionals were interviewed. Nurses were divided over extending their roles, with 123/220 (55.9%) wishing to extend roles in monitoring patients for possible adverse drug reactions (ADRs), 111/220 (50.5%) in adherence monitoring, 121/220 (55.0%) in prescribing and 122/220 (55.4%) in patient education. The best-qualified nurses were the most willing to increase involvement in monitoring patients for ADRs (aOR 13.00, 1.56-108.01). Interviews revealed that both nurses and doctors assumed the other profession was undertaking this monitoring. Respondents agreed that increasing nurses' involvement in medicines optimization would improve patient care, but expressed reservations about nurses' competencies. Collaboration between nurses and doctors was suboptimal (rated 7/10 at best) and between nurses and pharmacists even more so (6/10 at best).Conclusion
Juxtaposition of datasets identified problems with medicines optimization: although most respondents agreed that increasing nurses' involvement would positively impact practice, their educational preparation was a barrier. Only ~50% of nurses were willing to expand their roles to fill the hiatus in care identified and ensure that at least one profession was taking responsibility for ADR monitoring.Impact
To improve multiprofessional team working and promote patient safety, nurse leaders should ensure patients are monitored for possible ADRs by at least one profession. Initiatives expanding nurses' roles in medicines optimization and prescribing might be best targeted towards the more educated nurses, who have multidisciplinary support.https://eprints.bournemouth.ac.uk/34712/
Source: Europe PubMed Central
Did we do everything we could have? Nurses’ contributions to medicines optimisation: a mixed method study
Authors: Keeley, S., Logan, V., DeBaetselier, E., Dilles, T., Griffin, N., Akerman, K., Matthews, L., Rompaey, B. and Jordan, S.
Journal: Nursing Open
Volume: 8
Issue: 2
Pages: 592-606
ISSN: 2054-1058
Abstract:Aim To explore UK professionals’ interpretations of medicines optimization and expansion of nurses’ roles.
Design This mixed‐methods study sought professionals’ views on nurses’ involvement, competency and engagement in monitoring patients for adverse effects of medicines, monitoring adherence, prescribing and patient education.
Method An online survey and interviews were undertaken with nurses, doctors and pharmacists in Wales and England, May 2018 to July 2019.
Results In all, 220 nurses, 17 doctors and 62 pharmacists responded to the online survey, and 24 professionals were interviewed. Nurses were divided over extending their roles, with 123/220 (55.9%) wishing to extend roles in monitoring patients for possible adverse drug reactions (ADRs), 111/220 (50.5%) in adherence monitoring, 121/220 (55.0%) in prescribing and 122/220 (55.4%) in patient education. The best‐qualified nurses were the most willing to increase involvement in monitoring patients for ADRs (aOR 13.00, 1.56–108.01). Interviews revealed that both nurses and doctors assumed the other profession was undertaking this monitoring. Respondents agreed that increasing nurses’ involvement in medicines optimization would improve patient care, but expressed reservations about nurses’ competencies. Collaboration between nurses and doctors was suboptimal (rated 7/10 at best) and between nurses and pharmacists even more so (6/10 at best).
Conclusion Juxtaposition of datasets identified problems with medicines optimization: although most respondents agreed that increasing nurses’ involvement would positively impact practice, their educational preparation was a barrier. Only ~50% of nurses were willing to expand their roles to fill the hiatus in care identified and ensure that at least one profession was taking responsibility for ADR monitoring.
Impact To improve multiprofessional team working and promote patient safety, nurse leaders should ensure patients are monitored for possible ADRs by at least one profession. Initiatives expanding nurses’ roles in medicines optimization and prescribing might be best targeted towards the more educated nurses, who have multidisciplinary support.
https://eprints.bournemouth.ac.uk/34712/
Source: BURO EPrints